首页|期刊导航|Acta Biochimica et Biophysica Sinica|Astatine-211 and actinium-225:two promising nuclides in targeted alpha therapy
Acta Biochimica et Biophysica Sinica2025,Vol.57Issue(3):P.327-343,17.DOI:10.3724/abbs.2024206
Astatine-211 and actinium-225:two promising nuclides in targeted alpha therapy
摘要
关键词
astatine-211/actinium-225/radiopharmaceuticals/cancer/targeted alpha therapy分类
医药卫生引用本文复制引用
Dashan Zuo,Hui Wang,Boyi Yu,Qiang Li,Lu Gan,Weiqiang Chen..Astatine-211 and actinium-225:two promising nuclides in targeted alpha therapy[J].Acta Biochimica et Biophysica Sinica,2025,57(3):P.327-343,17.基金项目
supported by the grants from the Natural Science Foundation of Gansu Province(Nos.23JRRA569 and 21JR7RA106) (Nos.23JRRA569 and 21JR7RA106)
the National Natural Science Foundation of China(No.12065001) (No.12065001)
the West Light Foundation of the Chinese Academy of Sciences(No.xbzg-zdsys-201920) (No.xbzg-zdsys-201920)
the Key Deployment Project of Chinese Academy of Sciences(No.KFZDSW-222) (No.KFZDSW-222)
the Science and Technology Plan Project of Chengguan District(No.2022SHFZ0020). (No.2022SHFZ0020)